Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. 1986

T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen

Bone marrow from 22 histocompatible siblings was depleted of 98% of the lymphocytes using a combination of density flotation centrifugation followed by counterflow elutriation. Even with the marrow suppressive influence of methotrexate (MTX), the viability of the hematopoietic stem cells was not affected, as indicated by the normal repopulation after grafting in the evaluable patients. One patient (UPN 9) showed a primary graft failure, possibly resulting from persisting septicemia and long-term antibiotic therapy. Two patients have persistent host lymphocytes, one of whom was examined during relapse; the other remains in remission. Two patients did not receive immunosuppression after bone marrow transplantation (BMT), and acute graft-v-host disease (GVHD) developed in both. Nine patients received MTX as immunosuppression following BMT. GVHD did not develop in any of them, but fatal infections in the immediate posttransplant period developed in five patients. Eleven patients received cyclosporine (CsA) after transplantation. Beginning in week 5 after BMT, CsA was gradually replaced by MTX. Acute GVHD, substantial chronic GVHD, or fatal infections did not develop in any of these patients. Removal of 98% of the lymphocytes by counterflow centrifugation prevents development of acute GVHD, provided that immunosuppression is administered after BMT. Graft rejection was not observed, but the number of evaluable patients is limited at present.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002498 Centrifugation Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming

Related Publications

T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
March 1984, Lancet (London, England),
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
March 1991, Haematologica,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
September 1983, The Nursing clinics of North America,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
July 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
November 1983, Canadian Medical Association journal,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
January 1992, Progress in clinical and biological research,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
July 1990, Blood,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
July 1988, Transplant international : official journal of the European Society for Organ Transplantation,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
October 1993, Bone marrow transplantation,
T de Witte, and J Hoogenhout, and B de Pauw, and R Holdrinet, and J Janssen, and J Wessels, and W van Daal, and T Hustinx, and C Haanen
December 1993, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!